Koers Genomma Lab Internacional, S.A.B. de C.V.
Aandelen
LAB B
MX01LA010006
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
17,77 MXN | -4,51% | +6,53% | +25,49% |
Omzet 2024 * | 17,82 mld. 1,05 mld. 966 mln. | Omzet 2025 * | 19,12 mld. 1,12 mld. 1,04 mld. | Marktkapitalisatie | 16,8 mld. 987 mln. 911 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,98 mld. 116 mln. 107 mln. | Nettowinst (verlies) 2025 * | 2,22 mld. 131 mln. 121 mln. | EV/omzet 2024 * | 1,14 x |
Nettoschuld 2024 * | 3,45 mld. 202 mln. 187 mln. | Nettoschuld 2025 * | 2,83 mld. 166 mln. 153 mln. | EV/omzet 2025 * | 1,03 x |
K/w-verhouding 2024 * |
8,08
x | K/w-verhouding 2025 * |
8,18
x | Werknemers | 1.590 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
1,88% | Vrij verhandelbaar | 69,81% |
Recentste transcriptie over Genomma Lab Internacional, S.A.B. de C.V.
1 dag | -4,51% | ||
1 week | +6,53% | ||
1 maand | +6,34% | ||
3 maanden | +28,96% | ||
6 maanden | +25,32% | ||
Lopend jaar | +25,49% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | - |
Founder | - | 30-10-96 | |
Director of Finance/CFO | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Burkhard Wittek
BRD | Director/Board Member | 70 | 18-04-18 |
Founder | - | 30-10-96 | |
Director/Board Member | - | 01-01-98 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.07% | 15 M€ | -1,62% | - | |
0.04% | 32 M€ | +6,87% | - | |
0.01% | 4 M€ | -4,41% | - | |
0.01% | 112 M€ | +4,61% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
31-05-24 | 17,77 | -4,51% | 5 829 078 |
30-05-24 | 18,61 | +4,90% | 4 682 289 |
29-05-24 | 17,74 | +4,35% | 4 379 038 |
28-05-24 | 17 | +1,98% | 3 360 055 |
27-05-24 | 16,67 | -0,06% | 875 181 |
slotkoers Mexican S.E., 31 mei 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,49% | 986 mln. | |
+40,73% | 739 mld. | |
+32,83% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+15,00% | 240 mld. | |
+9,78% | 210 mld. | |
-5,52% | 206 mld. | |
+6,17% | 164 mld. |